Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up

Affiliations

• ¹ Department of Cardiovascular Medicine, University Hospitals Leuven, Belgium (P.R.S., K.V.).
• ² Department of Cardiovascular Sciences (P.R.S., F.V.d.W.), KU Leuven, Belgium.
• ³ Canadian Virtual Coordinating Center for Global Collaborative Cardiovascular Research, University of Alberta, Edmonton, Canada (R.C.W., K.R.B., P.W.A.).
• ⁴ Coronary Care Unit, National Institute of Cardiology, Mexico City (A.A.M.).
• ⁵ Department of Cardiology, University Clinical Center of Serbia, University of Belgrade, Serbia (A.D.R.).
• ⁶ Pirogov Russian National Research Medical University and City Clinical Hospital #15, Moscow, Russian Federation (O.V.A.).
• ⁷ Centre Hospitalier de Versailles, Service d'Aide médicale urgente 78 and Mobile Intensive Care Unit, France (Y.L.).
• ⁸ Cardiology Discipline, Pontifical Catholic University of Campinas School of Medicine, Brazil (J.F.K.S.).
• ⁹ Pontifica Universidad Católica de Chile, Santiago (P.S.).
• ¹⁰ Servicio de Urgencias y Emergencias 061 de La Rioja, Spain (F.R-O.).
• ¹¹ Department of Cardiology, Liverpool Hospital, Sydney, New South Wales, Australia (J.K.F.).
• ¹² University Clinical Center of Montenegro, University of Podgorica, Medical Faculty (L.B.M.).
• ¹³ Interuniversity Institute for Biostatistics and Statistical Bioinformatics (K.B.), KU Leuven, Belgium.
• ¹⁴ University Hasselt, Belgium (K.B.).
• ¹⁵ TDC, Aix en Provence, France (T.D.).